Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

Three distinct physical behavior types in fatigued patients with multiple sclerosis.

Braakhuis HEM, Berger MAM, van der Stok GA, van Meeteren J, de Groot V, Beckerman H, Bussmann JBJ; TREFAMS-ACE study group.

J Neuroeng Rehabil. 2019 Aug 23;16(1):105. doi: 10.1186/s12984-019-0573-1.

2.

Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes.

Wong YYM, Bruijstens AL, Barro C, Michalak Z, Melief MJ, Wierenga AF, van Pelt ED, Neuteboom RF, Kuhle J, Hintzen RQ.

Neurology. 2019 Sep 3;93(10):e968-e974. doi: 10.1212/WNL.0000000000008057. Epub 2019 Aug 5.

PMID:
31383792
3.

Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis.

van Langelaar J, Rijvers L, Janssen M, Wierenga-Wolf AF, Melief MJ, Siepman TA, de Vries HE, Unger PA, van Ham SM, Hintzen RQ, van Luijn MM.

Ann Neurol. 2019 Aug;86(2):264-278. doi: 10.1002/ana.25508. Epub 2019 Jun 19.

4.

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults.

de Mol CL, Wong Y, van Pelt ED, Wokke B, Siepman T, Neuteboom RF, Hamann D, Hintzen RQ.

Mult Scler. 2019 May 16:1352458519845112. doi: 10.1177/1352458519845112. [Epub ahead of print]

PMID:
31094288
5.

Time Is Brain and Spine-Reply.

van der Vuurst de Vries RM, Hintzen RQ.

JAMA Neurol. 2019 May 1;76(5):623-624. doi: 10.1001/jamaneurol.2019.0149. No abstract available.

PMID:
30830147
6.

Real-world validation of the 2017 McDonald criteria for pediatric MS.

Wong YYM, de Mol CL, van der Vuurst de Vries RM, van Pelt ED, Ketelslegers IA, Catsman-Berrevoets CE, Neuteboom RF, Hintzen RQ.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 14;6(2):e528. doi: 10.1212/NXI.0000000000000528. eCollection 2019 Mar.

7.

Response to Vilariño-Güell et al.

Mescheriakova JY, Verkerk J, Amin N, Uitterlinden AG, van Duijn CM, Hintzen RQ.

Mult Scler. 2019 Jun;25(7):1013-1015. doi: 10.1177/1352458518803794. Epub 2018 Oct 9. No abstract available.

PMID:
30298792
8.

Paediatric multiple sclerosis: early diagnosis as a first step.

Hintzen RQ.

Lancet Child Adolesc Health. 2018 Mar;2(3):161-162. doi: 10.1016/S2352-4642(18)30028-2. Epub 2018 Feb 1. No abstract available.

PMID:
30169249
9.

The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.

Rijvers L, Melief MJ, van der Vuurst de Vries RM, Stéphant M, van Langelaar J, Wierenga-Wolf AF, Hogervorst JM, Geurts-Moespot AJ, Sweep FCGJ, Hintzen RQ, van Luijn MM.

Eur J Immunol. 2018 Nov;48(11):1861-1871. doi: 10.1002/eji.201847623. Epub 2018 Sep 25.

10.

Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.

Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA; Dutch GBS Study Group.

J Peripher Nerv Syst. 2018 Dec;23(4):210-215. doi: 10.1111/jns.12286. Epub 2018 Sep 24.

PMID:
30151941
11.

Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome.

van der Vuurst de Vries RM, Mescheriakova JY, Wong YYM, Runia TF, Jafari N, Samijn JP, de Beukelaar JWK, Wokke BHA, Siepman TAM, Hintzen RQ.

JAMA Neurol. 2018 Nov 1;75(11):1392-1398. doi: 10.1001/jamaneurol.2018.2160.

12.

Chemical and genetic control of IFNγ-induced MHCII expression.

Wijdeven RH, van Luijn MM, Wierenga-Wolf AF, Akkermans JJ, van den Elsen PJ, Hintzen RQ, Neefjes J.

EMBO Rep. 2018 Sep;19(9). pii: e45553. doi: 10.15252/embr.201745553. Epub 2018 Jul 18.

13.

T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.

Wong YYM, van der Vuurst de Vries RM, van Pelt ED, Ketelslegers IA, Melief MJ, Wierenga AF, Catsman-Berrevoets CE, Neuteboom RF, Hintzen RQ.

Mult Scler. 2018 Nov;24(13):1715-1724. doi: 10.1177/1352458518786655. Epub 2018 Jul 18.

14.

Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family.

Mescheriakova JY, Verkerk AJ, Amin N, Uitterlinden AG, van Duijn CM, Hintzen RQ.

Mult Scler. 2019 Jun;25(7):909-917. doi: 10.1177/1352458518777202. Epub 2018 Jun 6.

15.

High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome.

van der Vuurst de Vries RM, Wong YYM, Mescheriakova JY, van Pelt ED, Runia TF, Jafari N, Siepman TA, Melief MJ, Wierenga-Wolf AF, van Luijn MM, Samijn JP, Neuteboom RF, Hintzen RQ.

Mult Scler. 2019 Jun;25(7):958-967. doi: 10.1177/1352458518775303. Epub 2018 May 18.

16.

T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.

van Langelaar J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, Spilt IM, Siepman TA, Dankers W, Verjans GMGM, de Vries HE, Lubberts E, Hintzen RQ, van Luijn MM.

Brain. 2018 May 1;141(5):1334-1349. doi: 10.1093/brain/awy069.

PMID:
29659729
17.

Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.

de Mol CL, Wong YYM, van Pelt ED, Ketelslegers IA, Bakker DP, Boon M, Braun KPJ, van Dijk KGJ, Eikelenboom MJ, Engelen M, Geleijns K, Haaxma CA, Niermeijer JMF, Niks EH, Peeters EAJ, Peeters-Scholte CMPCD, Poll-The BT, Portier RP, de Rijk-van Andel JF, Samijn JPA, Schippers HM, Snoeck IN, Stroink H, Vermeulen RJ, Verrips A, Visscher F, Vles JSH, Willemsen MAAP, Catsman-Berrevoets CE, Hintzen RQ, Neuteboom RF.

J Neurol. 2018 Jun;265(6):1310-1319. doi: 10.1007/s00415-018-8835-6. Epub 2018 Mar 22.

18.

Smoking at time of CIS increases the risk of clinically definite multiple sclerosis.

van der Vuurst de Vries RM, Mescheriakova JY, Runia TF, Siepman TAM, Wokke BHA, Samijn JPA, Hintzen RQ.

J Neurol. 2018 May;265(5):1010-1015. doi: 10.1007/s00415-018-8780-4. Epub 2018 Feb 20.

19.

Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.

Wong YYM, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C, van Pelt ED, Catsman-Berrevoets CE, Hintzen RQ, Deiva K, Lim MJ, Rostásy K, Neuteboom RF.

Eur J Neurol. 2018 May;25(5):782-786. doi: 10.1111/ene.13602. Epub 2018 Mar 9.

PMID:
29443442
20.

Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants.

Kreft KL, Van Nierop GP, Scherbeijn SMJ, Janssen M, Verjans GMGM, Hintzen RQ.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 12;4(6):e406. doi: 10.1212/NXI.0000000000000406. eCollection 2017 Nov.

Supplemental Content

Loading ...
Support Center